This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42504585
rdf:type
wikibase:Item
schema:description
επιστημονικό άρθρο vedecký článok artikull shkencor научная статья bilimsel makale artykuł naukowy 2007 nî lūn-bûn vitenskapelig artikkel article científic 2007年學術文章 სამეცნიერო სტატია 2007年學術文章 บทความทางวิทยาศาสตร์ наукова стаття, опублікована в травні 2007 wissenschaftlicher Artikel 2007年学术文章 مقالهٔ علمی artigo científico (publicado na 2007) scienca artikolo мақолаи илмӣ 2007年學術文章 article scientifique (publié 2007) videnskabelig artikel (udgivet 2007) article scientific naučni članak 2007년 논문 artikulong pang-agham мақолаи илмӣ 2007年学术文章 2007年學術文章 mokslinis straipsnis artículo científico publicado en 2007 bài báo khoa học مقالة علمية articolo scientifico 2007年学术文章 wetenschappelijk artikel artículu científicu espublizáu en 2007 научна статия 2007年學術文章 ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون vědecký článek tieteellinen artikkeli scientific article vetenskaplig artikel vitskapeleg artikkel tudományos cikk artigo científico 2007年学术文章 teaduslik artikkel научни чланак научни чланак 2007年學術文章 artigo científico (publicado na 2007) 2007年の論文 מאמר מדעי 2007年学术文章 articol științific գիտական հոդված
p:P577
wds:Q42504585-A7E594C0-AE39-4036-886B-8A7703DAF155
wdt:P577
2007-05-01T00:00:00Z
p:P2860
wds:Q42504585-A80B9B8A-A671-45ED-A45F-623740F7ABD3 wds:Q42504585-AD9B2FF4-053C-41E5-9257-FB6C60B0BD60 wds:Q42504585-83D7DD30-1E3D-4077-BFE5-179F36EC9A32 wds:Q42504585-896B4538-0D77-4C3F-B6FA-1FA991DDEDDE wds:Q42504585-90D0BADE-450E-455B-ADD4-A68605D1F42E wds:Q42504585-BE26CCAC-B181-48F3-8747-C9BE0A056659 wds:Q42504585-CABB39E4-2D93-426E-9021-D5391DAA2DD2 wds:Q42504585-D249E4AD-026F-4028-9CB6-C2C498259878 wds:Q42504585-B4CF673B-A796-4B6C-BCEB-1172AF90E928 wds:Q42504585-B7F7CA0A-4569-46BD-828C-A1E5996605E9 wds:Q42504585-BCEE75D6-C6EB-4464-B0AE-A1BDFB4673D3 wds:Q42504585-237C18DF-8857-43C0-87B3-8BECDC8302D3 wds:Q42504585-396966EA-06D2-44F6-9D0A-1A390F92AD9B wds:Q42504585-48AD47FF-6E22-4B57-B216-A8CF3E4A509B wds:Q42504585-0925EFBF-DDE8-4E69-B692-FC5190A956A6 wds:Q42504585-67A04947-D838-454E-A33E-70046AAE4582 wds:Q42504585-52B3C079-A0DF-49CB-B361-C6BA619273FD wds:Q42504585-F28EAC01-AC20-4185-A665-31EE2F7A50A2
wdt:P2860
wd:Q72671513 wd:Q68552334 wd:Q72015388 wd:Q35103993 wd:Q36072434 wd:Q42513776 wd:Q74520528 wd:Q34427077 wd:Q36107606 wd:Q73303059 wd:Q44134966 wd:Q34428346 wd:Q34421851 wd:Q43861556 wd:Q73489749 wd:Q71442152 wd:Q40459661 wd:Q44333576
p:P2093
wds:Q42504585-046A5B26-3DDA-4995-9A74-775351778B5F wds:Q42504585-17918DC4-DC0B-493E-BF1F-4BF3A03384F3 wds:Q42504585-6FF2F827-AD8E-44ED-ADC8-B8DCC95FBA94 wds:Q42504585-B1F57482-E97D-43AE-A865-0B44034F0F95 wds:Q42504585-B26DD560-4A58-4D0F-8129-F304B6B5BDAD wds:Q42504585-D962CFA0-01F9-4E89-AD93-49C259DCAB7E wds:Q42504585-F6F25A5F-10CE-434D-82CF-80751B8201FB wds:Q42504585-F7F1AB64-885F-4593-874A-BA05A65E8F2E
wdt:P2093
Tamir M Elias D Cohen IR Avron A Raz I Symer L Eldor R Metzger M
rdfs:label
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial
skos:prefLabel
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial
schema:name
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial
p:P1476
wds:Q42504585-0F5E018E-0EF1-47F3-90FC-106AE74336A2
wdt:P1476
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial
p:P304
wds:Q42504585-B0C33B48-2F25-49ED-A23C-C661AA123322
wdt:P304
292-298
p:P31
wds:Q42504585-7F52737E-E00D-427E-A995-1885CB567F5A
wdt:P31
wd:Q13442814
p:P921
wds:Q42504585-555FC8CC-55F2-4BA8-B428-00F27034DD4A wds:Q42504585-15ACA941-992C-4750-8BDA-E51159B4C6C2
wdt:P921
wd:Q124407 wd:Q42824440
p:P698
wds:Q42504585-7DB210CB-528B-43DE-8C41-41955B8A2664
wdtn:P698
n10:17124720
wdt:P698
17124720
p:P1433
wds:Q42504585-DB95534A-F80E-4820-9E82-585DD9A3F604
wdt:P1433
wd:Q15750056
p:P433
wds:Q42504585-626B4AD1-065F-4932-B35A-FE055661492F
p:P478
wds:Q42504585-F98F3DC0-EF64-4035-9068-3BD40F048A73
wdt:P433
4
wdt:P478
23
p:P356
wds:Q42504585-4D2A33CF-8CE0-4C7F-A869-EB5159A72F44
wdtn:P356
n8:DMRR.712
wdt:P356
10.1002/DMRR.712